Conclusion and identification of the core set of variables to be used in clinical investigations

Clinical and Experimental Rheumatology

Volumn 21, Issue 3 SUPPL. 29, 2003, Pages

  Valentini, Gabriele ^a   Medsger Jr , Thomas A ^b   Silman, Allan ^c   Bombardieri, Stefano ^d  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAPILLAROSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE COST; HUMAN; INFLAMMATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STANDARD; SYSTEMIC SCLEROSIS; FEMALE; HOSPITALIZATION; IMMUNOLOGY; MALE; METHODOLOGY; RHEUMATOLOGY;

FEMALE; HUMANS; MALE; RHEUMATOLOGY; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

EID: 0142026092     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. MEDSGER TA JR: Systemic sclerosis (scleroderma): Clinical aspects. In KOOPMAN WJ (Ed.): Arthritis and Allied Conditions. 14th ed., Philadelphia, Lippincott Williams & Wilkins 2001: 1590-624.
2. AKESSON A, FIORI G, KRIEG T, VAN DEN HOOGEN FHJ, SEIBOLD JR: Assessment of skin, joint, tendon and muscle involvement. Clin Exp Rheumatol 2003; 21 (Suppl. 29): S5-S8.
3. KAHALEH B, MEYER O, SCORZA R: Assessment of vascular involvement. Clin Exp Rheumatol 2003; 21 (Suppl. 29): S9-S14.
4. CLEMENTS PJ, BECVAR R, DROSOS AA, GHATTAS L, GABRIELLI A: Assessment of gastrointestinal involvement. Clin Exp Rheumatol 2003; 21 (Suppl. 29): S15-S18.
5. MATUCCI-CERINIC M, D'ANGELO S, DENTON C, VLACHOYIANNOPOULOS P, SILVER R: Assessment of lung involvement. Clin Exp Rheumatol 2003; 21 (Suppl. 29): S19-S23.
6. FERRI C, EMDIN M, NIELSEN H, BRUHLMANN P: Assessment of heart involvement. Clin Exp Rheumatol 2003; 21 (Suppl. 29): S24-S28.
7. STEEN VD, MAYES MD, MERKEL PA: Assessment of kidney involvement. Clin Exp Rheumatol 2003; 21 (Suppl. 29): S29-S31.
8. MCHUGH NJ, DISTLER O, GIACOMELLI R, RIEMEKASTEN G: Non organ based laboratory markers in systemic sclerosis. Clin Exp Rheumatol 2003; 21 (Suppl. 29): S32-S38.
9. VALENTINI G, SILMAN AJ, VEALE D: Assessment of disease activity. Clin Exp Rheumatol 2003; 21 (Suppl. 29): S39-S41.
10. MEDSGER TA JR, BOMBARDIERI S, CZIRIJAK L, SCORZA R, DELLA ROSSA A, BENCIVELLI W: Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003; 21 (Suppl. 29): S42-S46.
11. DELLA ROSSA A, VALENTINI G, BOMBARDIERI S et al.: European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients enrolled. Ann Rheum Dis 2001; 60: 585-91.